Disparities in healthcare in psoriatic arthritis: an analysis of 439 patients from 13 countries.
Florian LucassonUta KiltzUmut KalyoncuYing Ying LeungPenelope Esther PalominosJuan D CañeteRossana ScrivoAndra BalanescuEmanuelle DernisSandra MeisaluAdeline Ruyssen-WitrandMartin SoubrierSibel Zehra AydınLihi EderInna GaydukovaEnnio LubranoPascal RichetteElaine HusniLaura C CoatesMaarten P T de WitJosef S SmolenAna Maria OrbaiLaure GossecPublished in: RMD open (2022)
PsA patients from countries with the lowest GDP/capita, despite similar use of bDMARDs, were more likely to have high disease activity and worse disease impact. There is a need for more equity in healthcare.
Keyphrases
- healthcare
- disease activity
- rheumatoid arthritis
- systemic lupus erythematosus
- end stage renal disease
- prostate cancer
- rheumatoid arthritis patients
- ejection fraction
- ankylosing spondylitis
- newly diagnosed
- chronic kidney disease
- prognostic factors
- juvenile idiopathic arthritis
- peritoneal dialysis
- public health
- radical prostatectomy